Zeo ScientifiX, Inc.
🇺🇸United States
Clinical Trials
4
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- ZEO ScientifiX, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05643729
- Locations
- 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States
Zofin to Treat COVID-19 Long Haulers
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- ZEO ScientifiX, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT05228899
- Locations
- 🇺🇸
NewportNativeMD, Newport Beach, California, United States
🇺🇸Assuta Family Medical Group, North Hollywood, California, United States
🇺🇸Innovation Clinical Trials, Miami, Florida, United States
Expanded Access to Zofin for Patients With COVID-19
- Conditions
- SARS (Severe Acute Respiratory Syndrome)Acute Respiratory Distress SyndromeCovid19Corona Virus Infection
- First Posted Date
- 2020-12-08
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- ZEO ScientifiX, Inc.
- Registration Number
- NCT04657406
Zofin (Organicell Flow) for Patients With COVID-19
Phase 1
Completed
- Conditions
- Corona Virus InfectionSARSCOVID-19Acute Respiratory Distress Syndrome
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- ZEO ScientifiX, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04384445
- Locations
- 🇺🇸
George C. Shapiro, New York, New York, United States
News
No news found